Age-related differences in colon and rectal cancer survival: An analysis of United States SEER-18 data
Pilleron, S.; Withrow, D. R.; Nicholson, B. D.; Morris, E. J.
Show abstract
Age-related differences in colon and rectal cancer survival have been observed, even after accounting for differences in background mortality. To determine to what extent stage, tumour site, or histology could contribute to these differences, we estimated 1-year relative survival (RS) age stratified by these factors. Colon and rectal cancer cases diagnosed between 2012 and 2016 and followed up until 2017 were retrieved from 18 United States Surveillance Epidemiology and End Results cancer registries. For colon cancer, 1-year RS ranged from 87.8% [95% Confidence Interval: 87.5-88.2] in the 50-64-year-old age group to 62.3% [61.3-63.3] in the 85-99-year-old age group and for rectal cancer ranged from 92.3% [91.8-82.7] to 65.0% [62.3-67.5]. With respect to stage, absolute differences in RS between 50-64-year-old and 75-84-year-old in RS increased with increasing stage (from 6 [5-7] %-points in localized disease to 27 [25-29] %-points in distant disease) and were the highest for cancers of unknown stage (>28%-points). With respect to topography, age-related differences in survival were smallest for those in right-sided colon (8 [7-9] %-points) and largest for tumours of the colon without topography further specified (25 [21-29] %-points). While age-related differences in survival varied by histology and tumour site, the overall age-related differences in survival could not be explained by differences in distribution of these factors by age, consistent with a hypothesis that stage at diagnosis or treatment are more likely drivers. Incorporating data on geriatric conditions such as frailty and comorbidity would support further understanding of the age gap in colon and rectal cancer survival.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Age-related differences in cancer relative survival in the US: a SEER-18 analysis 99%
- Inequalities in relative cancer survival by race, immigration status, income, and education for 22 cancer sites in Canada, a cohort study 95%
- Cumulative COVID-19 incidence, mortality, and prognosis in cancer survivors: a population-based study in Reggio Emilia, Northern Italy 93%
Similar papers in this journal
- Pan-cancer analyses of the associations between 109 pre-existing conditions and cancer treatment patterns across 19 adult cancers 93%
- Disparities in outcomes among patients diagnosed with cancer associated with emergency department visits 91%
- Area-based socioeconomic inequalities in cancer mortality in Germany – widening, narrowing or reversing inequalities between 2003 and 2019? 91%
Similar papers in this journal
- Survival benefits of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma: evidence from a SEER-based retrospective cohort study 92%
- Survival benefit of adjuvant therapy following neoadjuvant therapy in patients with resected esophageal cancer: a retrospective cohort study 91%
- The impact of worldwide, national and sub-national severity distributions in Burden of Disease studies: a case study of individual cancer types in Scotland 91%
Similar papers in this journal
- A new colorectal cancer risk prediction model incorporating family history, personal and environmental factors 91%
- Site-specific cancer incidence by race and immigration status in Canada 2006-2015: a population-based data linkage study 90%
- A Quantitative Framework to Study Potential Benefits and Harms of Multi-cancer Early Detection Testing 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.